Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: Prevalence, antibiogram and resistance mechanisms

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 5, 2007, Pages 1010-1017

  Gad, Gamal F ^a   El Domany, Ramadan A ^b   Zaki, Sahar ^c   Ashour, Hossam M ^d  

^a Minia University   (Egypt)

^b Ein Helwan   (Egypt)

^c Universities and Research centers District   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

lactamases; Antibiotics; Efflux pumps; Nosocomial infections

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFALEXIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; EGYPT; HUMAN; MICROHABITAT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EGYPT; GENE EXPRESSION REGULATION, BACTERIAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 35449002547     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm348     Document Type: Article

References (37)

1. Valles J, Mariscal D, Cortes P et al. Patterns of colonization by Pseudomonas aeruginosa in intubated patients: A 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia. Intensive Care Med 2004; 30: 1768-75.
2. Fenner L, Richet H, Raoult D et al. Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test? Crit Care Med 2006; 34: 823-8.
3. Blanc DS, Petignat C, Janin B et al. Frequency and molecular diversity of Pseudomonas aeruginosa upon admissioh and during hospitalization: A prospective epidemiologic study. Clin Microbiol Infect 1998; 4: 242-7.
4. Livrelli V, De Champs C, Di Martino P et al. Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections. J Clin Microbiol 1996; 34: 1963-9.
5. Tassios PT, Gennimata V, Spaliara-Kalogeropoulou L et al. Multiresistant Pseudomonas aeruginosa serogroup O:11 outbreak in an intensive care unit. Clin Microbiol Infect 1997; 3: 621-8.
6. Gales AC, Jones RN, Turnidge J et al Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 Suppl 2: S146-55.
7. Marra AR, Bar K, Bearman GM et al. Systemic, inflammatory response syndrome in nosocomial bloodsteam infections with Pseudomonas aeruginosa and Enterococcus species: Comparison of elderly and nonelderly patients. J Am Geriatr Soc 2006; 54: 804-8.
8. Vincent JL, Sakr Y, Sprung CL et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34 344-53.
9. Harjai K, Mittal R, Chhibber S et al. Contribution of Tamm-Horsfall protein to virulence of Pseudomonas aeruginosa in urinary tract infection. Microbes Infect 2005; 7: 132-7.
10. Rello J, Allegri C, Rodriguqz A et al. Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure. Anesthesiology 2006; 105: 709-14.
11. Altoparlak U, Aktas F, Celebi D et al. Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Burns 2005; 31: 707-10.
12. Guidet B, Aegerter P, Gauzit R et al. Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005; 127: 942-51.
13. Hancock RE, Speert DP. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and impact on treatment. Drug Resist Updat 2000; 3: 247-55.
14. Collee JG, Fraser AG, Marmion BP et al. Mackie & McCartney Practical Medical Microbiology, 14th Edition. New York: Churchill Livingstone, 1996.
15. Barrow GI, Feltham RKA. Cowan and Steel's Manual for the Identification of Medical Bacteria, Third Edition. Cambridge, UK: Cambridge University Press, 1993.
16. Abd-El-Haleem D, Kheiralla ZH, Zaki S et al. Multiplex-PCR and PCR-RFLP assays to monitor water quality against pathogenic bacteria. J Environ Monit 2003; 5: 865-70.
17. Sykes RB. Methods for detecting β-lactamase. In: Reeves DS, Phillips I, Williams JD et al., ed. Laboratory Methods in Antimicrobial Chemotherapy. Edinburgh, UK: Churchill Livingstone, 1978; 64-9.
18. Lomovskaya O, Warren MS, Lee A et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.
19. Hsueh PR, Teng LJ, Yang PC et al. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol 1998; 36: 1347-51.
20. Pellegrino FL, Teixeira LM, Carvalho Md Mda G et al. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J Clin Microbiol 2002; 40 2420-4.
21. Kohler T, van Delden C, Curty LK et al. Overexpression of the MexEF-Oprl multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 2001; 183: 5213-22.
22. Bratu S, Quale J, Cebular S et al. Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: Molecular epidemiology and in vitro activity of polymyxin B. Eur J Clin Microbiol Infect Dis 2005; 24: 196-201.
23. Yetkin G, Otlu B, Cicek A et al. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Am J Infect Control 2006; 34: 188-92.
24. Gales AC, Sader HS, Jones RN. Urinary tract infection trends in Latin American hospitals: Report from the SENTRY antimicrobial survillance program (1997-2000). Diagn Microbiol Infect Dis 2002; 44: 289-99.
25. 1b integron overexpresses two efflux pumps and lacks OprD. J Antimicrob Chemother 2007; 60: 132-5.
26. VIM endemicity. J Antimicrob Chemother 2005; 56: 761-4.
27. Sahm DF, Critchley IA, Kelly LJ et al. Evaluation of current activities of fluorouinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance. Antimicrob Agents Chemother 2001; 45: 267-74.
28. Corona-Nakamura AL, Miranda-Novales MG, Leanos-Miranda B et al. Epidemiologic study of Pseudomonas aeruginosa in critical patients and reservoirs. Arch Med Res 2001; 32: 238-42.
29. Gencer S, Ak O, Benzonana N et al. Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey. Ann Clin Microbiol Antimicrob 2002; 1: 2.
30. Muller-Premru M, Gubina M. Serotype, antimicrobial-susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital. Zentralbl Bakteriol 2000; 289: 857-67.
31. al Naiemi N, Duim B, Bart A. A CTX-M extended-spectrum β-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Med Microbiol 2006; 55: 1607-8.
32. Wang C, Cai P, Chang D et al. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum β-lactamase. J Antimicrob Chemother 2006; 57: 1261-2.
33. Bell SM, Pham JN, Gatus BJ et al. Isolation of an extended spectrum β-lactamase producing Pseudomonas aeruginosa from a patient in a Sydney hospital. Pathology 2007; 39: 189-90.
34. Llanes C, Hocquet D, Vogne C et al. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother 2004; 48: 1797-802.
35. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 2004; 10: 12-26.
36. Oh H, Stenhoff J, Jalal S et al. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist 2003; 9: 323-8.
37. Pai H, Kim J, Kim J et al. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2001; 45: 480-4.